ClinVar Genomic variation as it relates to human health
NM_022437.3(ABCG8):c.1720G>A (p.Gly574Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_022437.3(ABCG8):c.1720G>A (p.Gly574Arg)
Variation ID: 4968 Accession: VCV000004968.20
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2p21 2: 43875377 (GRCh38) [ NCBI UCSC ] 2: 44102516 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 13, 2015 Oct 8, 2024 Jan 11, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_022437.3:c.1720G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_071882.1:p.Gly574Arg missense NM_001357321.2:c.1717G>A NP_001344250.1:p.Gly573Arg missense NC_000002.12:g.43875377G>A NC_000002.11:g.44102516G>A NG_008884.2:g.48436G>A LRG_1182:g.48436G>A LRG_1182t1:c.1720G>A LRG_1182p1:p.Gly574Arg Q9H221:p.Gly574Arg - Protein change
- G574R, G573R
- Other names
-
NM_022437.2(ABCG8):c.1720G>A(p.Gly574Arg)
- Canonical SPDI
- NC_000002.12:43875376:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Exome Aggregation Consortium (ExAC) 0.00006
The Genome Aggregation Database (gnomAD), exomes 0.00006
The Genome Aggregation Database (gnomAD) 0.00022
Trans-Omics for Precision Medicine (TOPMed) 0.00027
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ABCG8 | - | - |
GRCh38 GRCh37 |
744 | 810 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
May 31, 2018 | RCV000005256.13 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 11, 2024 | RCV000726168.7 | |
Pathogenic/Likely pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
May 10, 2023 | RCV000993692.7 | |
Pathogenic (1) |
criteria provided, single submitter
|
Oct 5, 2020 | RCV002408452.2 | |
ABCG8-related disorder
|
Likely pathogenic (1) |
no assertion criteria provided
|
Mar 21, 2024 | RCV003407278.6 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(May 10, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Sitosterolemia 1
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002023963.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Jan 11, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003267395.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 574 of the ABCG8 protein (p.Gly574Arg). … (more)
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 574 of the ABCG8 protein (p.Gly574Arg). This variant is present in population databases (rs137852988, gnomAD 0.01%). This missense change has been observed in individual(s) with sitosterolemia (PMID: 11099417, 12124998, 15996216, 25073796, 32088153, 34969652). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 4968). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCG8 protein function with a positive predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on ABCG8 function (PMID: 15054092). This variant disrupts the p.Gly574 amino acid residue in ABCG8. Other variant(s) that disrupt this residue have been observed in individuals with ABCG8-related conditions (PMID: 11452359), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Likely pathogenic
(May 31, 2018)
|
criteria provided, single submitter
Method: curation
|
Sitosterolemia 1
Affected status: unknown
Allele origin:
unknown
|
SIB Swiss Institute of Bioinformatics
Accession: SCV000803594.1
First in ClinVar: May 03, 2018 Last updated: May 03, 2018 |
Comment:
This variant is interpreted as a Likely Pathogenic, for Sitosterolemia, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: PM2 => Absent from controls … (more)
This variant is interpreted as a Likely Pathogenic, for Sitosterolemia, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PS3 => Well-established functional studies show a deleterious effect (PMID:15054092). (less)
|
|
Pathogenic
(Jun 02, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000342579.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 4
Sex: mixed
|
|
Likely pathogenic
(Apr 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Sitosterolemia 1
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000430535.3
First in ClinVar: Dec 06, 2016 Last updated: May 24, 2019 |
Comment:
The ABCG8 c.1720G>A (p.Gly574Arg) variant has been found in a homozygous state in at least six individuals with sitosterolemia, five of whom are from the … (more)
The ABCG8 c.1720G>A (p.Gly574Arg) variant has been found in a homozygous state in at least six individuals with sitosterolemia, five of whom are from the Amish population (Berge et al. 2000; Lee et al. 2001; Solca et al. 2005; Horenstein et al. 2013; Ruiz et al. 2015). Horenstein et al. (2013) determined that the carrier frequency for the p.Gly574Arg variant was 0.76% in the healthy Amish population and identified a statistically significant increase in plant sterol plasma levels in carriers compared to non-carriers. Control data are unavailable for this variant, which is reported at a frequency of 0.00009 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the evidence, the p.Gly574Arg variant is classified as likely pathogenic for sitosterolemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. (less)
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
SITOSTEROLEMIA
Affected status: yes
Allele origin:
germline
|
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
Accession: SCV004046322.1
First in ClinVar: Oct 21, 2023 Last updated: Oct 21, 2023 |
Comment:
This variant has been previously reported as a compound heterozygous change with a nonsense variant in one individual with Sitosterolemia and as homozygous change in … (more)
This variant has been previously reported as a compound heterozygous change with a nonsense variant in one individual with Sitosterolemia and as homozygous change in several individuals with Sitosterolemia (PMID: 11264985, 12124998, 25073796, 15996216). Functional studies have shown that this variant is associated decreased protein maturation (PMID: 15054092). The c.1720G>A (p.Gly574Arg) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.006% (18/282058) and thus is presumed to be rare. The allele frequency in the Amish population is 1.5% (15/984), suggesting a founder effect (PMID: 23241408). The c.1720G>A (p.Gly574Arg) variant affects a moderately conserved amino acid and is predicted by multiple in silico tools to have a discordant effect on protein function. Based on the available evidence, the c.1720G>A (p.Gly574Arg) variant is classified as Pathogenic. (less)
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Sitosterolemia 1
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Neuberg Centre For Genomic Medicine, NCGM
Accession: SCV004100597.1
First in ClinVar: Nov 04, 2023 Last updated: Nov 04, 2023 |
Comment:
The missense variant p.G574R in ABCG8 (NM_022437.3) has been reported as a common variant in the Amish population (Horenstein RB et al,2013; Ruiz XD et … (more)
The missense variant p.G574R in ABCG8 (NM_022437.3) has been reported as a common variant in the Amish population (Horenstein RB et al,2013; Ruiz XD et al). The variant has been submitted to ClinVar as Pathogenic.The p.G574R variant is observed in 11/1,13,234 (0.0097%) alleles from individuals of European (Non-Finnish) background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.G574R missense variant is predicted to be damaging by both SIFT and PolyPhen2. The nucleotide c.1720 in ABCG8 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. The variant has been detected in a heterozygous state in her parents. (less)
Clinical Features:
Fatigue (present) , Chronic fatigue (present) , Pain (present) , Headache (present) , Seizure (present) , Migraine (present)
|
|
Pathogenic
(Oct 05, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiovascular phenotype
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002716531.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The p.G574R pathogenic mutation (also known as c.1720G>A), located in coding exon 11 of the ABCG8 gene, results from a G to A substitution at … (more)
The p.G574R pathogenic mutation (also known as c.1720G>A), located in coding exon 11 of the ABCG8 gene, results from a G to A substitution at nucleotide position 1720. The glycine at codon 574 is replaced by arginine, an amino acid with dissimilar properties. This mutation has been reported in several homozygous sitosterolemia cases and has been described as an Amish founder mutation (Kwiterovich PO et al. Lancet, 1981 Feb;1:466-9; Berge KE et al. Science, 2000 Dec;290:1771-5; Heimerl S et al. Hum. Mutat., 2002 Aug;20:151; Solcà C et al. Clin. Genet., 2005 Aug;68:174-8; Horenstein RB et al, 2013 Feb;33:413-9). One in vitro study indicates that this alteration may impact protein function (Graf GA et al. J. Biol. Chem., 2004 Jun;279:24881-8). Based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Thonghin N et al, 2018 12;18:17). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. (less)
|
|
Pathogenic
(Aug 01, 2005)
|
no assertion criteria provided
Method: literature only
|
SITOSTEROLEMIA 1
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000025434.3
First in ClinVar: Apr 04, 2013 Last updated: Nov 21, 2019 |
Comment on evidence:
In an Amish American patient with sitosterolemia (STSL1; 210250), Berge et al. (2000) identified a G-to-A transition at nucleotide 1720 of the ABCG8 gene, resulting … (more)
In an Amish American patient with sitosterolemia (STSL1; 210250), Berge et al. (2000) identified a G-to-A transition at nucleotide 1720 of the ABCG8 gene, resulting in a gly574-to-arg (G574R) substitution. The patient died of coronary artery disease at 13 years of age. This patient was the proband of the extensive Amish kindred studied by Beaty et al. (1986) and also by Kwiterovich et al., 1981. In a Swiss woman with sitosterolemia who had typical xanthomas and also mitral and aortic valvular disease, Solca et al. (2005) identified homozygosity for the G574R mutation in the ABCG8 gene. Extended haplotype analysis of this patient and 2 Amish-Mennonite patients with the same mutation revealed that the Swiss patient and 1 Amish-Mennonite patient had identical SNPs, with minor differences between the 2 Amish-Mennonite patients. Solca et al. (2005) concluded that the G574R mutation in the Amish-Mennonite population originated in Europe more than 250 years ago. (less)
|
|
Likely pathogenic
(Mar 21, 2024)
|
no assertion criteria provided
Method: clinical testing
|
ABCG8-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004106383.2
First in ClinVar: Nov 20, 2023 Last updated: Oct 08, 2024 |
Comment:
The ABCG8 c.1720G>A variant is predicted to result in the amino acid substitution p.Gly574Arg. This variant has been reported in patients with autosomal recessive sitosterolemia … (more)
The ABCG8 c.1720G>A variant is predicted to result in the amino acid substitution p.Gly574Arg. This variant has been reported in patients with autosomal recessive sitosterolemia and is a frequent variant among the Amish population (Berge et al. 2000. PubMed ID: 11099417; Heimerl et al. 2002. PubMed ID: 12124998; Horenstein et al. 2013. PubMed ID: 23241408). Carriers of variants in ABCG8 are reported to have elevated levels of plant sterols and hypercholesterolemia (Horenstein et al. 2013. PubMed ID: 23241408; Berge et al. 2000. PubMed ID: 11099417). Hemolytic anemia, stomatocyte formation, and macrothrombocytopenia are common hematologic findings in patients with sitosterolemia (Wang et al. 2014. PubMed ID: 24166850; Escolá-Gil et al. 2014. PubMed ID: 24821603). This variant is reported in 0.0093% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemia. | Xia Y | Journal of clinical lipidology | 2022 | PMID: 34969652 |
ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia. | Reeskamp LF | Journal of clinical lipidology | 2020 | PMID: 32088153 |
Novel features in the structure of P-glycoprotein (ABCB1) in the post-hydrolytic state as determined at 7.9 Å resolution. | Thonghin N | BMC structural biology | 2018 | PMID: 30545335 |
20-year-old amish woman with abdominal pain, retroperitoneal mass, and hyperlipidemia. | Ruiz XD | Arthritis care & research | 2015 | PMID: 25073796 |
The ABCG8 G574R variant, serum plant sterol levels, and cardiovascular disease risk in the Old Order Amish. | Horenstein RB | Arteriosclerosis, thrombosis, and vascular biology | 2013 | PMID: 23241408 |
Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots. | Solcà C | Clinical genetics | 2005 | PMID: 15996216 |
Missense mutations in ABCG5 and ABCG8 disrupt heterodimerization and trafficking. | Graf GA | The Journal of biological chemistry | 2004 | PMID: 15054092 |
Mutations in the human ATP-binding cassette transporters ABCG5 and ABCG8 in sitosterolemia. | Heimerl S | Human mutation | 2002 | PMID: 12124998 |
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. | Lu K | American journal of human genetics | 2001 | PMID: 11452359 |
Genetic basis of sitosterolemia. | Lee MH | Current opinion in lipidology | 2001 | PMID: 11264985 |
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. | Berge KE | Science (New York, N.Y.) | 2000 | PMID: 11099417 |
Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. | Beaty TH | American journal of human genetics | 1986 | PMID: 3706300 |
Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. | Kwiterovich PO Jr | Lancet (London, England) | 1981 | PMID: 6110091 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ABCG8 | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs137852988 ...
HelpRecord last updated Oct 13, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.